Top Management Message

Daiichi Sankyo's mission is to contribute to the enrichment of the quality of life around the world through the creation of innovative pharmaceuticals and through the provision of pharmaceuticals that address diverse medical needs.

The business environment facing the pharmaceutical industry continues to evolve in Japan and around the world. In the midst of these changing conditions, we are working to realize our 2025 vision of being a Global Pharma Innovator with Competitive Advantage in Oncology. To that end, we are striving to satisfy unmet medical needs as a developer of new drugs, including vaccines, generic and OTC drugs, that meet a variety of medical needs.

As a leader in the healthcare industry, we recognize that we have multiple responsibilities to our many stakeholders. We not only have a responsibility to provide the pharmaceuticals that are indispensable today to healthcare systems around the world, but we must also fund the research and development that ensures the availability of tomorrow's innovative medicines. We also have a responsibility to support the communities in which we live and work. We commit to achieving these important goals while delivering earnings growth to our shareholders and doing our utmost to earn the trust of all our stakeholders. By embracing these responsibilities, we hope to be a company worthy of representing Japan as a cutting-edge global enterprise.

Thank you for your continued support.

George Nakayama
Representative Director,
Chairman and CEO

Sunao Manabe
Representative Director,
President and COO

Company Profile

As a global company, we aim to constantly extend our business activities.

SBOBET,SBOBET Asia sitemap Freeslot gclubslot Mobile W88 918kisslogin gclub slot SBOBET,SBOBET Asia Slot V||||||||||||||||||||||||||||||||||||||||||